Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery: A 1-year follow-up study

Giuseppe Mercante, Alessandra Masiello, Isabella Sperduti, Giovanni Cristalli, Raul Pellini, Giuseppe Spriano

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background To evaluate quality-of-life (QoL), swallowing and voice in patients with base of tongue (BOT) tumors treated with transoral robotic surgery (TORS) alone without any adjuvant treatment. Methods The study was a prospective, single-center cohort trial. Swallowing, QoL and voice were evaluated in 13 patients with T1 or T2 oropharyngeal carcinomas of the BOT. Patients underwent evaluation using the following: a dysphagia score (DS); fiberoptic endoscopic evaluation-of-swallowing with the penetration aspiration scale (PAS); the MD Anderson Dysphagia Inventory (MDADI); and the Voice Handicap Index-10 (VHI-10). Results Subjective (DS) and objective (PAS) evaluation of swallowing produced mean scores of 1.08, 2.23 and 1.46 before surgery and at 6 and 12 months after surgery, respectively, for both tests. A significant difference was found when comparing DS and PAS data at baseline and 6 months after surgery; while no difference was observed between the baseline and 12 months after surgery. The mean values of the MDADI and VHI scores recorded before surgery, and at 6 and 12 months after surgery did not show any statistical difference. Conclusions Objective swallowing deterioration in the first 6 months after TORS alone for BOT tumors was possible, but complete recovery of deglutition was observed within 12 months. No changes were reported in the patients' self-perceived status of swallowing and voice dysfunction, and related QoL after 1 year.

Original languageEnglish
Pages (from-to)1561-1566
Number of pages6
JournalJournal of Cranio-Maxillofacial Surgery
Volume43
Issue number8
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Robotics
Tongue
Deglutition
Quality of Life
Deglutition Disorders
Neoplasms
Equipment and Supplies
Carcinoma

Keywords

  • Base of tongue
  • Oropharyngeal cancer
  • Quality of life
  • Swallowing
  • TORS
  • Trans-oral robotic surgery

ASJC Scopus subject areas

  • Oral Surgery
  • Otorhinolaryngology
  • Surgery

Cite this

Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery : A 1-year follow-up study. / Mercante, Giuseppe; Masiello, Alessandra; Sperduti, Isabella; Cristalli, Giovanni; Pellini, Raul; Spriano, Giuseppe.

In: Journal of Cranio-Maxillofacial Surgery, Vol. 43, No. 8, 01.10.2015, p. 1561-1566.

Research output: Contribution to journalArticle

Mercante, Giuseppe ; Masiello, Alessandra ; Sperduti, Isabella ; Cristalli, Giovanni ; Pellini, Raul ; Spriano, Giuseppe. / Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery : A 1-year follow-up study. In: Journal of Cranio-Maxillofacial Surgery. 2015 ; Vol. 43, No. 8. pp. 1561-1566.
@article{906489fb88ad41f88afe8f63a8dfcd29,
title = "Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery: A 1-year follow-up study",
abstract = "Background To evaluate quality-of-life (QoL), swallowing and voice in patients with base of tongue (BOT) tumors treated with transoral robotic surgery (TORS) alone without any adjuvant treatment. Methods The study was a prospective, single-center cohort trial. Swallowing, QoL and voice were evaluated in 13 patients with T1 or T2 oropharyngeal carcinomas of the BOT. Patients underwent evaluation using the following: a dysphagia score (DS); fiberoptic endoscopic evaluation-of-swallowing with the penetration aspiration scale (PAS); the MD Anderson Dysphagia Inventory (MDADI); and the Voice Handicap Index-10 (VHI-10). Results Subjective (DS) and objective (PAS) evaluation of swallowing produced mean scores of 1.08, 2.23 and 1.46 before surgery and at 6 and 12 months after surgery, respectively, for both tests. A significant difference was found when comparing DS and PAS data at baseline and 6 months after surgery; while no difference was observed between the baseline and 12 months after surgery. The mean values of the MDADI and VHI scores recorded before surgery, and at 6 and 12 months after surgery did not show any statistical difference. Conclusions Objective swallowing deterioration in the first 6 months after TORS alone for BOT tumors was possible, but complete recovery of deglutition was observed within 12 months. No changes were reported in the patients' self-perceived status of swallowing and voice dysfunction, and related QoL after 1 year.",
keywords = "Base of tongue, Oropharyngeal cancer, Quality of life, Swallowing, TORS, Trans-oral robotic surgery",
author = "Giuseppe Mercante and Alessandra Masiello and Isabella Sperduti and Giovanni Cristalli and Raul Pellini and Giuseppe Spriano",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.jcms.2015.06.024",
language = "English",
volume = "43",
pages = "1561--1566",
journal = "Journal of Maxillofacial Surgery",
issn = "1010-5182",
publisher = "Churchill Livingstone",
number = "8",

}

TY - JOUR

T1 - Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery

T2 - A 1-year follow-up study

AU - Mercante, Giuseppe

AU - Masiello, Alessandra

AU - Sperduti, Isabella

AU - Cristalli, Giovanni

AU - Pellini, Raul

AU - Spriano, Giuseppe

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background To evaluate quality-of-life (QoL), swallowing and voice in patients with base of tongue (BOT) tumors treated with transoral robotic surgery (TORS) alone without any adjuvant treatment. Methods The study was a prospective, single-center cohort trial. Swallowing, QoL and voice were evaluated in 13 patients with T1 or T2 oropharyngeal carcinomas of the BOT. Patients underwent evaluation using the following: a dysphagia score (DS); fiberoptic endoscopic evaluation-of-swallowing with the penetration aspiration scale (PAS); the MD Anderson Dysphagia Inventory (MDADI); and the Voice Handicap Index-10 (VHI-10). Results Subjective (DS) and objective (PAS) evaluation of swallowing produced mean scores of 1.08, 2.23 and 1.46 before surgery and at 6 and 12 months after surgery, respectively, for both tests. A significant difference was found when comparing DS and PAS data at baseline and 6 months after surgery; while no difference was observed between the baseline and 12 months after surgery. The mean values of the MDADI and VHI scores recorded before surgery, and at 6 and 12 months after surgery did not show any statistical difference. Conclusions Objective swallowing deterioration in the first 6 months after TORS alone for BOT tumors was possible, but complete recovery of deglutition was observed within 12 months. No changes were reported in the patients' self-perceived status of swallowing and voice dysfunction, and related QoL after 1 year.

AB - Background To evaluate quality-of-life (QoL), swallowing and voice in patients with base of tongue (BOT) tumors treated with transoral robotic surgery (TORS) alone without any adjuvant treatment. Methods The study was a prospective, single-center cohort trial. Swallowing, QoL and voice were evaluated in 13 patients with T1 or T2 oropharyngeal carcinomas of the BOT. Patients underwent evaluation using the following: a dysphagia score (DS); fiberoptic endoscopic evaluation-of-swallowing with the penetration aspiration scale (PAS); the MD Anderson Dysphagia Inventory (MDADI); and the Voice Handicap Index-10 (VHI-10). Results Subjective (DS) and objective (PAS) evaluation of swallowing produced mean scores of 1.08, 2.23 and 1.46 before surgery and at 6 and 12 months after surgery, respectively, for both tests. A significant difference was found when comparing DS and PAS data at baseline and 6 months after surgery; while no difference was observed between the baseline and 12 months after surgery. The mean values of the MDADI and VHI scores recorded before surgery, and at 6 and 12 months after surgery did not show any statistical difference. Conclusions Objective swallowing deterioration in the first 6 months after TORS alone for BOT tumors was possible, but complete recovery of deglutition was observed within 12 months. No changes were reported in the patients' self-perceived status of swallowing and voice dysfunction, and related QoL after 1 year.

KW - Base of tongue

KW - Oropharyngeal cancer

KW - Quality of life

KW - Swallowing

KW - TORS

KW - Trans-oral robotic surgery

UR - http://www.scopus.com/inward/record.url?scp=84941933405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941933405&partnerID=8YFLogxK

U2 - 10.1016/j.jcms.2015.06.024

DO - 10.1016/j.jcms.2015.06.024

M3 - Article

AN - SCOPUS:84941933405

VL - 43

SP - 1561

EP - 1566

JO - Journal of Maxillofacial Surgery

JF - Journal of Maxillofacial Surgery

SN - 1010-5182

IS - 8

ER -